Tomorrow at #RelapseConference23, we will present data showing hematologic protection in patients treated with trem-cel after repeat Mylotarg dosing. This data suggests that trem-cel shielded healthy cells from the on-target toxicity typically seen with Mylotarg treatment. Learn more: https://lnkd.in/epbEczwT Cc ASTCT The EBMT
